Solubility & Bioavailability: Difficult Beasts to Tame – Quotient Sciences Dr. Dolly Jacob, Director of Integrated Development Services speaks with Drug Development & Delivery
Poor solubility is becoming increasingly prevalent in drug pipelines. Infact, across the pharmaceutical industry, about 70 percent of drugs that enter development possess insufficient aqueous solubility for adequate and consistent gastrointestinal absorption.
In a recent article with Drug Development & Delivery, Quotient Sciences, Dr. Jacob discussed how the industries solubility and bioavailability challenges increase formulation complexity, raise failure rates, and drive-up development costs. At Quotient Sciences we find solutions to unlocking the potential of each small molecule we work with.
Read more:
External URL: https://www.quotientsciences.com/news/dr-dolly-jacob-solubility-bioavailability-challenge/
By Arcinova
463 Views
Recent Posts
- Explore the Impact of Verifying Carbon Capture Technologies
- ITS wins Supplier of the Year at the ISPE UK Affiliate Annual Awards
- Cembre MG4 | The Newest Thermal Printer for Identification & Labelling | Available From Thorne & Derrick
- Share your expertise at ICPVT15: International Conference on Pressure Vessel Technology
- Minimising GWR Probe Build Up with the Magnetrol Eclipse 706
Back to News >
Share this
Most Recent Post
© Copyright. North East of England Process Industry Cluster (NEPIC) 2015
Built by iTCHYROBOT